Trastuzumab: possible publication bias.
Metcalfe
Scott
S
Pharmaceutical Management Agency (PHARMAC), Wellington 6143, New Zealand. scott.metcalfe@pharmac.govt.nz
Burgess
Carl
C
Laking
George
G
Evans
Jackie
J
Wells
Susan
S
Crausaz
Steffan
S
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008958:Models, Molecular; D017594:Publication Bias; D016032:Randomized Controlled Trials as Topic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab